Ingersoll Rand Inc.

source: coverage-next-full ticker: IR step: "01" title: Business Overview — Ingersoll Rand Inc. created: 2026-05-29

Step 01 — Business Overview

Company Identity

Ingersoll Rand Inc. is a global provider of mission-critical flow creation and industrial technologies. The company was created in February 2020 when Gardner Denver Holdings merged with the Industrial segment of Ingersoll-Rand plc (the climate/HVAC assets were spun off as Trane Technologies). The combined entity retained the iconic "Ingersoll Rand" brand given its 150-year industrial heritage and customer recognition.

CEO Vicente Reynal, who led Gardner Denver's highly successful private equity-to-public transformation under KKR, has continued the same operating philosophy at IR — disciplined M&A integration via the IRX operating model, aggressive margin improvement, and compounding through bolt-on acquisitions.

Operating Segments

Industrial Technologies & Services (ITS) — ~77% of Revenue

ITS is the core legacy Gardner Denver business. It manufactures and services compressed air systems, gas compression equipment, blowers, and vacuum systems. Products include:

• Compressed Air Systems: Rotary screw, reciprocating, and centrifugal compressors under brands including Ingersoll Rand, CompAir, Elmo Rietschle, Gardner Denver, and Tamrotor.
• Blowers & Vacuum Systems: Positive displacement blowers, rotary vane, and dry-screw vacuum pumps.
• Power Tools & Assembly Tools: Pneumatic and electric tools under Ingersoll Rand, Chicago Pneumatic, and Desoutter brands; heavy-duty industrial fastening systems.
• Aftermarket Services: A critical component — ~35-40% of ITS revenue comes from parts, service, and consumables. This recurring revenue stream generates significantly higher margins than new equipment.

ITS End Markets: General manufacturing, chemicals, food & beverage, energy, automotive, semiconductor, and infrastructure.

ITS Adjusted EBITDA Margin: ~26-28% (FY2024 est.), reflecting high aftermarket mix and lean IRX execution.

Precision & Science Technologies (PST) — ~23% of Revenue

PST was built largely through acquisition, anchored by ILC Dover (acquired 2021) and Seepex (acquired 2022). It serves more specialized, higher-growth end markets:

• Life Sciences & Medical: Flexible containment solutions (ILC Dover), specialty diaphragm pumps, peristaltic pumps for pharmaceutical manufacturing, bioprocessing, and drug delivery.
• Specialty Pumps: Seepex progressive cavity pumps (food, wastewater, energy), ARO fluid management, and Milton Roy dosing/metering pumps.
• Industrial Air: Specialty compressed air for food/beverage, electronics, and clean-room environments.

PST End Markets: Pharmaceutical, bioprocessing, medical devices, wastewater treatment, food & beverage, semiconductor.

PST Adjusted EBITDA Margin: ~26-28% (FY2024 est.), premium to ITS given specialty mix.

Geographic Mix

International exposure (~55%) provides diversification but creates FX translation headwinds/tailwinds. IR actively hedges transactional FX risk but not translation risk.

Business Model Characteristics

Revenue Model:

• New equipment/capital sales (~60%)
• Aftermarket parts, service contracts, consumables (~40%)

The aftermarket revenue mix is a structural advantage — it is:

1. Higher margin than OEM equipment
2. Recurring and contractual in nature
3. Sticky (customers prefer OEM parts/service for warranty/safety)
4. Less cyclical than new equipment capex

Pricing Power: IR has demonstrated consistent pricing above inflation. The company achieved 3-5% annual price realization in FY2022-2024, offsetting raw material inflation and driving margin expansion.

The IRX Operating System

IRX (Ingersoll Rand Excellence) is a proprietary continuous improvement framework modeled on Danaher Business System principles. It encompasses:

• Lean manufacturing and waste elimination
• 80/20 analysis for portfolio simplification
• Value-based pricing discipline
• M&A integration playbook — standardized 100-day integration process

IRX is the primary mechanism through which IR extracts margin improvement from acquisitions (typically 400-600 bps of margin expansion within 3 years). This system is central to the IR investment thesis.

Brand Portfolio

Key brands: Ingersoll Rand, Gardner Denver, CompAir, ARO, Milton Roy, Seepex, ILC Dover, Thomas, NASH, Robuschi, Elmo Rietschle, Chicago Pneumatic, Desoutter.

Competitive Positioning

IR occupies #1 or #2 market position in compressed air/vacuum systems and specialty pumps globally. The company competes with Atlas Copco (dominant in compressors), Parker Hannifin (diversified motion/control), SPX FLOW, and a long tail of regional specialists.

source: coverage-next-full ticker: IR step: "04" title: Financial Snapshot — 3-Year P&L Summary created: 2026-05-29

Step 04 — Financial Snapshot

3-Year Income Statement Summary

Note: "Adjusted" figures exclude purchase accounting amortization (~$250-280M/year), restructuring charges, M&A transaction costs, and other non-recurring items. The large D&A relative to EBIT reflects substantial intangible amortization from the Gardner Denver + Ingersoll-Rand Industrial merger and subsequent acquisitions.

Margin Bridge Analysis

Gross Margin Expansion (40.8% → 43.0%): Driven by:

1. Pricing actions (3-5% annually) outpacing material cost inflation
2. Mix shift toward aftermarket/service (higher margin) and PST specialty products
3. IRX lean manufacturing driving COGS reduction
4. Supply chain normalization post-COVID (freight, semiconductors, steel)

EBITDA Margin Expansion (22.2% → 24.6%): Driven by:

1. Gross margin flow-through
2. SG&A leverage on higher revenue base
3. IRX-driven operating efficiency in acquired businesses
4. Partially offset by continued integration investments

Target EBITDA Margin: Management has guided to ~28-30% Adj. EBITDA margin by FY2027, implying continued 150-200 bps of annual margin expansion — ambitious but supported by ITS operational leverage and PST margin normalization post-ILC Dover integration.

Key Profitability Metrics

GAAP vs. Adjusted Reconciliation Notes

The large gap between GAAP EPS ($1.68) and Adjusted EPS ($3.09) in FY2024 primarily reflects:

1. Purchase Accounting Amortization: ~$260M annually from intangible assets created by the 2020 merger and subsequent acquisitions. This is non-cash and will decline over time as intangibles are fully amortized.
2. Restructuring: ~$40-60M annually as IR integrates acquisitions and optimizes its manufacturing footprint.
3. M&A Transaction Costs: Episodic deal costs (~$20-40M annually).

Investors should watch amortization carefully — it is projected to decline ~$20-30M annually through 2028, providing an EPS tailwind even at constant operating performance.

Free Cash Flow

The step-up in FCF from FY2022 to FY2023 partly reflects normalization of working capital after the 2021-2022 supply chain disruption (IR built inventory buffers that were subsequently released). Ongoing FCF generation is expected to be ~$1B+ annually, providing significant capital allocation optionality.

Balance Sheet Summary

The leverage profile has been declining steadily from the peak post-ILC Dover acquisition (~3.5x in 2021). Management targets ~2.0x net leverage as the steady-state level, which permits continued bolt-on M&A while maintaining investment-grade credit.

Valuation Context

At a share price of approximately $70-75 (mid-2025 estimate), IR trades at:

• ~16-18x NTM Adjusted EPS
• ~13-15x NTM Adjusted EBITDA
• ~16-18x NTM FCF

These multiples represent a discount to Atlas Copco (20-25x EV/EBITDA) but a premium to broader U.S. industrials (12-14x EV/EBITDA), reflecting IR's premium-quality business model, compounding M&A strategy, and margin expansion runway.